Average Co-Inventor Count = 3.87
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Pfizer Corporation (10 from 4,455 patents)
2. Onkure, Inc. (7 from 7 patents)
3. Array Biopharma Inc. (6 from 329 patents)
4. University of Colorado (3 from 1,376 patents)
5. Genentech, Inc. (1 from 3,221 patents)
6. Astrazeneca Ab (1 from 1,500 patents)
7. Astrazeneca Sb (1 from 1 patent)
26 patents:
1. 12252511 - Process for the preparation of cyclic depsipeptides
2. 11739123 - Process for the preparation of cyclic depsipeptides
3. 11339150 - Benzimidazole compounds as HDAC6 inhibitors
4. 11203602 - Thioester prodrugs of macrocycles as inhibitors of histone deacetylases
5. 11053284 - Process for the preparation of cyclic depsipeptides
6. 10689419 - Process for the preparation of cyclic depsipeptides
7. 10508122 - Heterocyclic hydroxamic acids as protein deacetylase inhibitors and dual protein deacetylase-protein kinase inhibitors and methods of use thereof
8. RE47690 - Heterocyclic hydroxamic acids as protein deacetylase inhibitors and dual protein deacetylase-protein kinase inhibitors and methods of use thereof
9. 10100089 - Process for the preparation of cyclic depsipeptides
10. 9840520 - Heterocyclic hydroxamic acids as protein deacetylase inhibitors and dual protein deacetylase-protein kinase inhibitors and methods of use thereof
11. 9024040 - Processes for preparing benzimidazole compounds
12. 8680114 - AKT protein kinase inhibitors
13. 8501956 - Benzimidazole compounds
14. 8383832 - Process for preparing benzimidazole compounds
15. 8039637 - Process for preparing benzimidazole compounds